Content area
Jade Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Jade Biosciences Inc (Jade Biosciences) is a biotechnology company. It focuses on the development of therapies to treat inflammation and immune-related diseases. The company’s lead program candidate, JADE-001, is an antibody designed to block the APRIL (a proliferation-inducing ligand) protein to treat IgA nephropathy. Jade Biosciences’ pipeline also includes JADE-002 and JADE-003 drug candidates for undisclosed indications. The company was funded by Fairmount, Ven rock, Bradwell, Deep Track Capital, Frazier Life Sciences, RA Capital, Great Point Partners, and Soleus Capital. Jade Biosciences is headquartered in Waltham, Massachusetts, the US
Jade Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.